Evidence map›Paper›PMID 31476158›Full record

ArticleJournal of Alzheimer's disease : JAD2019

Fine Particulate Matter Exposure and Cerebrospinal Fluid Markers of Vascular Injury.

Rachel M Shaffer, Lianne Sheppard, Elaine R Peskind, Jing Zhang, Sara D Adar, Ge Li

Open access · greenAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Rachel M ShafferDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Lianne SheppardDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.
Elaine R PeskindVA Northwest Network Mental Illness Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA.
Jing ZhangDepartment of Pathology, University of Washington, Seattle, WA, USA.
Sara D AdarDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, WA, USA.
Ge LiVA Northwest Network Mental Illness Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, USA.
University of Washington · USGeriatric Research Education and Clinical Center · USUniversity of Michigan–Ann Arbor · USVA Northwest Network · US

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI GRABOWSKI, THOMAS J. · 1985 to 2019
$57.2M
Biostatistics, Epidemiologic & Bioinformatic Training in Environmental HealthT32ES015459 · NIEHS · UNIVERSITY OF WASHINGTON · PI June T. Spector · 2009 to 2026
$10.6M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
Peptide Biomarkers for Alzheimer DiseaseR01AG056711 · NIA · UNIVERSITY OF WASHINGTON · PI SHI, MIN · 2017 to 2021
$4.1M
Air Pollution, the Aging Brain and Alzheimer's DiseaseR01ES026187 · NIEHS · UNIVERSITY OF WASHINGTON · PI LI, GAIL, SHEPPARD, ELIZABETH A LIANNE · 2016 to 2020
$3.8M
Peptide Biomarkers for Parkinson DiseaseU01NS091272 · NINDS · UNIVERSITY OF WASHINGTON · PI SHI, MIN · 2016 to 2020
$2.1M
Fine particulate air pollution, neuropathologies, and Alzheimers disease.F31ES030972 · NIEHS · UNIVERSITY OF WASHINGTON · PI SHAFFER, RACHEL · 2019 to 2019
$45k
NIA NIH HHS P50 AG005136NIA NIH HHS R01 AG056711NIA NIH HHS T32 AG052354NIEHS NIH HHS F31 ES030972NIEHS NIH HHS R01 ES026187NIEHS NIH HHS T32 ES015459NINDS NIH HHS U01 NS091272
6 · The paper itself

Abstract

backgroundCerebrovascular diseases play an important role in dementia. Air pollution is associated with cardiovascular disease, with growing links to neurodegeneration. Prior studies demonstrate associations between fine particulate matter (PM2.5) and biomarkers of endothelial injury in the blood; however, no studies have evaluated these biomarkers in cerebrospinal fluid (CSF).

objectiveWe evaluate associations between short-term and long-term PM2.5 exposure with CSF vascular cell adhesion molecule-1 (VCAM-1) and e-selectin in cognitively normal and mild cognitive impairment (MCI)/Alzheimer's disease (AD) individuals.

methodsWe collected CSF from 133 community volunteers at VA Puget Sound between 2001-2012. We assigned short-term PM2.5 from central monitors and long-term PM2.5 based on annual average exposure predictions linked to participant addresses. We performed analyses stratified by cognitive status and adjusted for key covariates with tiered models. Our primary exposure windows for the short-term and long-term analyses were 7-day and 1-year averages, respectively.

resultsAmong cognitively normal individuals, a 5 μg/m3 increase in 7-day and 1-year average PM2.5 was associated with elevated VCAM-1 (7-day: 35.4 (9.7, 61.1) ng/ml; 1-year: 51.8 (6.5, 97.1) ng/ml). A 5 μg/m3 increase in 1-year average PM2.5, but not 7-day average, was associated with elevated e-selectin (53.3 (11.0, 95.5) pg/ml). We found no consistent associations among MCI/AD individuals.

conclusionsWe report associations between short-term and long term PM2.5 and CSF biomarkers of vascular damage in cognitively normal adults. These results are aligned with prior research linking PM2.5 to vascular damage in other biofluids as well as emerging evidence of the role of PM2.5 in neurodegeneration.

Indexed as

AgedAged, 80 and overAir PollutantsAir PollutionAlzheimer DiseaseBiomarkersCognitionCohort StudiesEnvironmental ExposureE-SelectinFemaleHumansMaleMiddle AgedParticle SizeParticulate MatterAir PollutantsBiomarkersE-SelectinParticulate MatterVascular Cell Adhesion Molecule-1Alzheimer’s diseasebiomarkerscellular adhesion moleculescerebrospinal fluidcerebrovascular disordersdementiaparticulate matter

Identifiers

PMID31476158
PMCPMC7147945
OpenAlexW2993087784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.